Biotech

All Articles

Metsera join Amneal to latch down GLP-1 supply

.With very early phase 1 records today out in bush, metabolic disease attire Metsera is actually thr...

Rivus posts information to support muscle-sparing weight problems drug insurance claims

.Rivus Pharmaceuticals has introduced the data behind its own phase 2 obesity win in cardiac arrest ...

BMS pays $110M to form T-cell therapy treaty, assisting Top buy time to develop prioritized pipeline

.Bristol Myers Squibb is actually spending Best Medicine $110 thousand upfront to establish reagents...

Generate increases yet another $1B-plus Big Pharma collaboration

.Novartis has printer inked an offer potentially worth more than $1 billion with Flagship-founded Ge...

Metsera GLP-1 records piece shows 7.5% weight management at 36 times

.Lately debuted Metsera is actually unfolding some phase 1 information for its own GLP-1 receptor ag...

Flagship hopes biotechs group to Mirai to enhance hereditary meds

.Among the genetic medicines branches race, Main Pioneering is unveiling a brand-new business to hel...

BioAge eyes $180M coming from IPO, exclusive positioning for being overweight tests

.BioAge Labs is actually considering about $180 million in first proceeds coming from an IPO and a p...

Merck's LAG-3 combination fails intestines cancer period 3 research study

.An attempt through Merck &amp Co. to open the microsatellite stable (MSS) metastatic colorectal can...

Spanish VC closes $200M lifestyle sciences fund

.Spain-based Asabys Partners has closed a fund of 180 million europeans ($ 200 thousand), loan that ...

BioAge produces $198M coming from IPO as weight problems biotech signs up with Nasdaq

.BioAge Labs is generating almost $200 million through its Nasdaq IPO this morning, with the profits...